CHAPTER 1. Industry Overview of Digital Pathology Market
1.1. Definition and Scope
1.1.1. Definition of Digital Pathology
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Digital Pathology Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Digital Pathology Market By Product
1.2.3. Digital Pathology Market By Application
1.2.4. Digital Pathology Market By End-use
1.2.5. Digital Pathology Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Digital Pathology Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Digital Pathology Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Digital Pathology Market By Product
5.1. Introduction
5.2. Digital Pathology Revenue By Product
5.2.1. Digital Pathology Revenue (USD Billion) and Forecast, By Product, 2020-2032
5.2.2. Software
5.2.2.1. Software Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Storage System
5.2.3.1. Storage System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Device
5.2.4.1. Device Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Digital Pathology Market By Application
6.1. Introduction
6.2. Digital Pathology Revenue By Application
6.2.1. Digital Pathology Revenue (USD Billion) and Forecast, By Application, 2020-2032
6.2.2. Drug Discovery & Development
6.2.2.1. Drug Discovery & Development Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Disease Diagnosis
6.2.3.1. Disease Diagnosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Academic Research
6.2.4.1. Academic Research Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Digital Pathology Market By End-use
7.1. Introduction
7.2. Digital Pathology Revenue By End-use
7.2.1. Digital Pathology Revenue (USD Billion) and Forecast, By End-use, 2020-2032
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Diagnostic Labs
7.2.3.1. Diagnostic Labs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Biotech & Pharma Companies
7.2.4.1. Biotech & Pharma Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Academic & Research Institutes
7.2.5.1. Academic & Research Institutes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Digital Pathology Market By Country
8.1. North America Digital Pathology Market Overview
8.2. U.S.
8.2.1. U.S. Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
8.2.2. U.S. Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
8.2.3. U.S. Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
8.3. Canada
8.3.1. Canada Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3.2. Canada Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
8.3.3. Canada Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Digital Pathology Market By Country
9.1. Europe Digital Pathology Market Overview
9.2. U.K.
9.2.1. U.K. Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. U.K. Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.3. U.K. Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.3. Germany
9.3.1. Germany Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Germany Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.3. Germany Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.4. France
9.4.1. France Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
9.4.2. France Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
9.4.3. France Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.5. Spain
9.5.1. Spain Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
9.5.2. Spain Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
9.5.3. Spain Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
9.6.2. Rest of Europe Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
9.6.3. Rest of Europe Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Digital Pathology Market By Country
10.1. Asia Pacific Digital Pathology Market Overview
10.2. China
10.2.1. China Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. China Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.3. China Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.3. Japan
10.3.1. Japan Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Japan Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.3. Japan Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.4. India
10.4.1. India Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. India Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.3. India Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.5. Australia
10.5.1. Australia Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.2. Australia Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.3. Australia Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.6. South Korea
10.6.1. South Korea Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.2. South Korea Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.3. South Korea Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
10.7.2. Rest of Asia-Pacific Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
10.7.3. Rest of Asia-Pacific Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Digital Pathology Market By Country
11.1. Latin America Digital Pathology Market Overview
11.2. Brazil
11.2.1. Brazil Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. Brazil Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.3. Brazil Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.3. Mexico
11.3.1. Mexico Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. Mexico Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.3. Mexico Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. Rest of Latin America Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.3. Rest of Latin America Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Digital Pathology Market By Country
12.1. Middle East & Africa Digital Pathology Market Overview
12.2. GCC
12.2.1. GCC Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.2. GCC Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.3. GCC Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.3. South Africa
12.3.1. South Africa Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.2. South Africa Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.3. South Africa Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Digital Pathology Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.2. Rest of Middle East & Africa Digital Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.3. Rest of Middle East & Africa Digital Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Digital Pathology Market
13.1. Digital Pathology Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Digital Pathology Market
13.2.4. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Philips Healthcare
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Philips Healthcare 2022 Digital Pathology Business Regional Distribution
14.1.4. Product/Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Leica Biosystems Nussloch GmbH (Danaher Corporation)
14.3. Roche Diagnostics
14.4. Hamamatsu Photonics K.K.
14.5. Ventana Medical Systems, Inc. (Roche)
14.6. Olympus Corporation
14.7. Nikon Corporation
14.8. Sectra AB
14.9. Visiopharm A/S
14.10. Indica Labs, Inc.
14.11. Huron Digital Pathology Inc.
14.12. 3DHISTECH Ltd.
The market size of digital pathology was USD 1.1 Billion in 2022.
The CAGR of digital pathology is 10.3% during the analysis period of 2023 to 2032.
The key players operating in the global market are including Philips Healthcare, Leica Biosystems Nussloch GmbH (Danaher Corporation), Roche Diagnostics, Hamamatsu Photonics K.K., Ventana Medical Systems, Inc. (Roche), Olympus Corporation, Nikon Corporation, Sectra AB, Visiopharm A/S, Indica Labs, Inc., Huron Digital Pathology Inc., and 3DHISTECH Ltd.
North America held the dominating position in digital pathology industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of digital pathology during the analysis period of 2023 to 2032.
The current trends and dynamics in the digital pathology industry include increasing demand for efficient and accurate diagnostic solutions, advancements in imaging technology and slide scanning systems, and growing prevalence of chronic diseases, especially cancer.
The academic research application held the maximum share of the digital pathology industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date